Vimarsana
Biggest News Aggregation in the World

Page 4 - Phase Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phase Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phase Labs Today - Breaking & Trending Today

Q3 2023 EPS Estimates for ProPhase Labs, Inc. (NASDAQ:PRPH) Cut by Analyst - Vimarsana News

Q3 2023 EPS Estimates for ProPhase Labs, Inc. (NASDAQ:PRPH) Cut by Analyst

ProPhase Labs, Inc. (NASDAQ:PRPH – Free Report) – HC Wainwright dropped their Q3 2023 EPS estimates for ProPhase Labs in a report released on Monday, August 14th. HC Wainwright analyst Y. Chen now anticipates that the company will post earnings per share of ($0.19) for the quarter, down from their prior forecast of ($0.17). HC […]

ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call. - Vimarsana News

ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.

Garden City, NY, Aug. 10, 2023 -- ProPhase Labs, Inc. Conference Call and Webcast Details Management will host a conference call at 11:00 AM ET, Thursday, August 10, 2023, to provide an update... -Today at 10:40 am- MarketScreener

Head to Head Comparison: ProPhase Labs (NASDAQ:PRPH) versus RAPT Therapeutics (NASDAQ:RAPT) - Vimarsana News

Head to Head Comparison: ProPhase Labs (NASDAQ:PRPH) versus RAPT Therapeutics (NASDAQ:RAPT)

ProPhase Labs (NASDAQ:PRPH – Free Report) and RAPT Therapeutics (NASDAQ:RAPT – Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership. Profitability This table compares ProPhase Labs and RAPT Therapeutics’ […]

Head-To-Head Review: RAPT Therapeutics (NASDAQ:RAPT) and ProPhase Labs (NASDAQ:PRPH) - Vimarsana News

Head-To-Head Review: RAPT Therapeutics (NASDAQ:RAPT) and ProPhase Labs (NASDAQ:PRPH)

RAPT Therapeutics (NASDAQ:RAPT – Free Report) and ProPhase Labs (NASDAQ:PRPH – Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, valuation and risk. Analyst Ratings This is a breakdown of recent ratings […]

PRPH Stock Price | ProPhase Labs Inc. Stock Quote (U.S.: Nasdaq) - Vimarsana News

PRPH Stock Price | ProPhase Labs Inc. Stock Quote (U.S.: Nasdaq)

PRPH | Complete ProPhase Labs Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.